These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4120544)

  • 1. [Cytomorphological, immunochemical and therapeutic aspects of multiple myeloma].
    Maroncelli P; Casalino C
    Minerva Med; 1973 Feb; 64(8):337-57. PubMed ID: 4120544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP; Jessen B; Videbaek A
    Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma without initial paraproteins.
    Kim I; Harley JB; Weksler B
    Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526
    [No Abstract]   [Full Text] [Related]  

  • 4. Current management of multiple myeloma.
    Korst DR
    Wis Med J; 1968 Nov; 67(11):566-8. PubMed ID: 5747569
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myeloma and myelomonocytic leukemia. Role of melphalan. Ultrastructural and cytoenzymologic study].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golenzer C; Adotti F; Dryll A; Roujeau J
    Pathol Eur; 1973; 8(4):287-98. PubMed ID: 4523953
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognosis of myelomatosis on treatment with prednisone and cytostatics.
    Hansen OP; Jessen B; Videbaek A
    Scand J Haematol; 1973; 10(4):282-90. PubMed ID: 4764610
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of plasmacytoma].
    Gassel WD; Sodomann CP
    Ther Ggw; 1980 Sep; 119(9):980-1005. PubMed ID: 7466705
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of multiple myeloma.
    Ungaro P
    J Ky Med Assoc; 1973 Dec; 71(12):805-7. PubMed ID: 4766737
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gamma-D-paraproteinemia. Clinical case contribution based on 2 studies].
    Spengler GA; Bütler R; Pflugshaupt R; Lopez V; Barandun S
    Schweiz Med Wochenschr; 1967 Feb; 97(6):170-8. PubMed ID: 4175061
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary treatment results in myeloma disease using a cytostatic preparation].
    Iavorkovskiĭ LI; Soloveĭ DIa; Udris OIu; Riauzova LIu; Bliumental' RIa
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):36-40. PubMed ID: 7301789
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.
    Bergsagel DE; Cowan DH; Hasselback R
    Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Binding of beta-lipoprotein by an IgA paraprotein: an antigen-antibody reaction?].
    Noseda G; Bütler R; Schlumpf E; Brunner E; Riesen W
    Schweiz Med Wochenschr; 1971 Jun; 101(24):893-9. PubMed ID: 5004031
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of multiple myeloma.
    Kyle RA; Maldonado JE; Bayrd ED
    Mayo Clin Proc; 1968 Oct; 43(10):730-7. PubMed ID: 5711940
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute leukemia and myeloma].
    Riedler GF; Vorburger E; Maier C
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1592-4. PubMed ID: 4509370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognosis and therapy of multiple myeloma].
    Sonntag RW
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1247-51. PubMed ID: 675217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cellular substratum in plasmacytoma].
    Micu D
    Stud Cercet Med Interna; 1971; 12(6):511-22. PubMed ID: 4944649
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma. A clinical review.
    Rosen BJ
    Med Clin North Am; 1975 Mar; 59(2):375-86. PubMed ID: 1078867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IgM myeloma].
    Assaf ME; Pizzolato MA; De María HE; Gasparini S; Burucua JE
    Sangre (Barc); 1983; 28(5):642-7. PubMed ID: 6420914
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
    Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.